HIV/AIDS Clinical Trials

HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy

Condition: Chronic Hepatitis C Infection in HIV Infected Persons; HIV Infections

NCT ID: NCT00215839

Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients

Condition: HIV Infections

NCT ID: NCT00000733

Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT01332955

Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00085917

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Condition: Liver Cirrhosis; Hepatitis C Virus; HIV Infection

NCT ID: NCT01006031

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00059358

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Condition: HIV Infections; Chronic Hepatitis C

NCT ID: NCT00196586

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

Condition: Hepatitis C, Chronic; HIV Infections

NCT ID: NCT00553930

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

Condition: HIV Infections

NCT ID: NCT00356486

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Condition: HIV Infection; Hepatitis C Infection

NCT ID: NCT00991289

An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals

Condition: HIV Infections; HCV

NCT ID: NCT00489385

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

Condition: HIV Infections; Hepatitis C, Chronic; Treatment Failure

NCT ID: NCT00221650

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00008463

A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals

Condition: HIV Infections

NCT ID: NCT00000772

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects

Condition: Hepatitis C,; Human Immunodeficiency Virus

NCT ID: NCT01667731

Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)

Condition: Hepatitis C, Chronic; Hepacivirus; HIV Infections

NCT ID: NCT00687544

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Condition: HIV/HCV Co-infection; HIV Infections

NCT ID: NCT00866021

A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.

Condition: HIV Infections

NCT ID: NCT00000833

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

Condition: HCV Coinfection; HIV-1 Infection

NCT ID: NCT01335529

Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00018031

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

Condition: HCV Coinfection; HIV Infection

NCT ID: NCT01529073

Part A: Drug Interaction Study of GS-7977 and Antiretroviral Therapy(ART) Combinations in Human Immunodeficiency Virus and Hepatitis C Virus (HIV/HCV) Co-infected Patients. Part B: Phase 2, Open-Label Study to Investigate Efficacy and Safety of GS-7977 for 12 Weeks in HIV/HCV Co-infected Patients.

Condition: Hepatitis C; HIV

NCT ID: NCT01565889

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

Condition: Chronic Hepatitis C; HIV Infections

NCT ID: NCT00296972

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437476

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00470210

Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)

Condition: Chronic Hepatitis C; Hepatitis C; HIV Infections

NCT ID: NCT00736242

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

Condition: Hepatitis C Infection; HIV Infection

NCT ID: NCT01185028

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00983853

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437684

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects

Condition: Chronic Hepatitis C; Human Immunodeficiency Virus

NCT ID: NCT01783678

A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients

Condition: HIV Infections

NCT ID: NCT00000699

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00015652

Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis B; Hepatitis C

NCT ID: NCT00051077

Withdrawn(En español)

The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection

Condition: HIV Infections

NCT ID: NCT00002298

NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection

Condition: Hepatitis C; HIV; Anemia

NCT ID: NCT00315432

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies

Condition: Chronic Hepatitis C; HIV Infections

NCT ID: NCT00530972

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01482767

Recruiting(En español)

Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment

Condition: Human Immunodeficiency Virus; Chronic Hepatitis C

NCT ID: NCT00909129

A Study to Evaluate Safety and Efficacy of Boceprevir-response Guided Therapy in Controlled HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Condition: HCV and HIV Seropositive Coinfection

NCT ID: NCT01718301

Not yet recruiting

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

Condition: HIV Infections; Hepatitis C; HCV Infection

NCT ID: NCT00959699

Treatment of Hepatitis C in Hemophilic Patients With HIV

Condition: HIV Infections; Hepatitis C; Hemophilia

NCT ID: NCT00055341

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders

Condition: HCV-HIV Co-Infection

NCT ID: NCT01725542

Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00612755

Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance

Condition: HIV-1 and Hepatitis C Co-Infection

NCT ID: NCT00665353

Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin

Condition: Anemia; Neutropenia; Hepatitis C Virus; HIV Infections

NCT ID: NCT00194857

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00100581

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00031343

Management of Hepatitis C in HIV-Infected and Uninfected IDUs

Condition: Hepatitis C Virus; HIV Infections

NCT ID: NCT00496912

Open Label Study to Evaluate the Safety, Efficacy, Viral Kinetics, Genetic, Epigenetic, and Proteomic Expression of Weekly Peginterferon Alpha 2a and Ribavirin Therapy for Chronic Hepatitis C in Latino Subjects With and Without HIV Co-infection

Condition: Hepatitis C; HIV

NCT ID: NCT01182298

Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C

Condition: HIV Infections; Hepatitis C, Chronic

NCT ID: NCT00122616

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Condition: Hepatitis; HIV/AIDS

NCT ID: NCT01443923

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Condition: Chronic Hepatitis C

NCT ID: NCT01513941

TMC435-TiDP16-C212 - Trial of TMC435 in Genotype 1 Hepatitis C and Human Immunodeficiency Virus Co-Infected Patients

Condition: Hepatitis C; Human Immunodeficiency Virus (HIV)

NCT ID: NCT01479868

Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00150904

A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems

Condition: HIV Infections

NCT ID: NCT00001015

Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Condition: Chronic Hepatitis C; Co-Infection HIV-HCV

NCT ID: NCT00611819

Effects of Ribavirin on Zidovudine or Stavudine

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00021632

Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis C; Liver Disease

NCT ID: NCT00078403

Treatment of Acute Hepatitis C Virus in HIV Co-Infection

Condition: Hepatitis C Virus; Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00845676

The Raltegravir and Ribavirin Pharmacokinetics (PK) Study

Condition: HIV Infections

NCT ID: NCT00982553

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Condition: Hepatitis C, Chronic

NCT ID: NCT00353418

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

Condition: Chronic Hepatitis C

NCT ID: NCT01684787

Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus

Condition: Hepatitis C, Genotype 1

NCT ID: NCT01471574

A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Condition: Hepatitis C

NCT ID: NCT01467479

Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients

Condition: Hepatitis C; Depressive Disorder, Major; Depressive Disorder; Depression; HIV Infections

NCT ID: NCT00655226

Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy

Condition: HIV; Hepatitis C; Infections

NCT ID: NCT00747539

Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection

Condition: Thrombocytopenia; Hepatitis C; HIV Infections

NCT ID: NCT00239733

Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00132210

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV

Condition: Hepatitis

NCT ID: NCT00901524

Telaprevir Open-Label Study in Co-Infected Patients

Condition: Hepatitis C, Chronic

NCT ID: NCT01500616

Trial of Citalopram for the Prevention of Depression

Condition: Depression; HIV Infections; Hepatitis C

NCT ID: NCT00317746

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Inmunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Condition: Hepatitis C, Chronic

NCT ID: NCT01399619

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

Condition: Chronic Hepatitis C

NCT ID: NCT00526448

Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients

Condition: Hepatitis C

NCT ID: NCT00703560

Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects

Condition: Influenza

NCT ID: NCT00979251